The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy
Open accessAbstract
Phenylephrine and noradrenaline (α-adrenergic agonism) or isoprenaline (β-adrenergic agonism) stimulated protein synthesis rates, increased the activity of the atrial natriuretic factor gene promoter and activated mitogen-activated protein kinase (MAPK). The EC50 for MAPK activation by noradrenaline was 2–4 μM and that for isoprenaline was 0.2–0.3 μM. Maximal activation of MAPK by isoprenaline was inhibited by the β-adrenergic antagonist, propranolol, whereas the activation by noradrenaline was inhibited by the α1-adrenergic antagonist, prazosin. FPLC on a Mono-Q column separated two peaks of MAPK (p42MAPK and p44MAPK) and two peaks of MAPK-activating activity (MEK) activated by isoprenaline or noradrenaline. Prolonged phorbol ester exposure partially down-regulated the activation of MAPK by noradrenaline but not by isoprenaline. This implies a role for protein kinase C in MAPK activation by noradrenaline but not isoprenaline. A role for cyclic AMP in activation of the MAPK pathway was eliminated when other agonists that elevate cyclic AMP in the cardiac myocyte did not activate MAPK. In contrast, MAPK was activated by exposure to ionomycin, Bay K8644 or thapsigargin that elevate intracellular Ca2+. Furthermore, depletion of extracellular Ca2+ concentrations with bis-(o-aminophenoxy)ethane-NNN´N´-tetra-acetic acid (BAPTA) or blocking of the L-type Ca2+ channel with nifepidine or verapamil inhibited the response to isoprenaline without inhibiting the responses to noradrenaline. We conclude that α- and β-adrenergic agonists can activate the MEK/MAPK pathway in the heart by different signalling pathways. Elevation of intracellular Ca2+ rather than cyclic AMP appears important in the activation of MAPK by isoprenaline in the cardiac myocyte.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inositol trisphosphate and calcium signalling
Berridge, M. J. (1993) · Nature · doi:10.1038/361315a0 · Cited by 6,545
Protein kinase C and lipid signaling for sustained cellular responses
Nishizuka, Y. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.7.7737456 · Cited by 2,499
Cited by
Signal Transduction through MAP Kinase Cascades
(1998) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60765-4 · Cited by 1,759
Adrenergic and Muscarinic Receptors in the Human Heart
Brodde, O.-E., & Michel, M. C. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01425-x · Cited by 673
Bogoyevitch, M. A., Gillespie-Brown, J., Ketterman, A. J., Fuller, S. J., Ben-Levy, R., Ashworth, A., Marshall, C. J., & Sugden, P. H. (1996) · Circulation Research · doi:10.1161/01.res.79.2.162 · Cited by 525
Self-citationZhong, H., & Minneman, K. P. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00222-8 · Cited by 386
Abel, E. D., Kaulbach, H. C., Tian, R., Hopkins, J. C. A., Duffy, J., Doetschman, T., Minnemann, T., Boers, M.-E., Hadro, E., Oberste-Berghaus, C., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci7605 · Cited by 358
Metadata
- Authors
- BOGOYEVITCH, M. A., ANDERSSON, M. B., GILLESPIE-BROWN, J., CLERK, A., GLENNON, P. E., FULLER, S. J., & SUGDEN, P. H.
- Venue
- Biochemical Journal
- Publisher
- Portland Press Ltd.
- Published
- 1996-02-15
- Volume
- 314
- Issue
- 1
- Pages
- 115-121
- ISSN
- 0264-6021 (ISSN-L)
- 1470-8728
- OpenAlex
- W1875111347
- Cited by
- 167
- References
- 2
- FWCI
- 5.07
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. https://app.cochat.ai/papers/10.1042/bj3140115
- The paper
- BOGOYEVITCH, M. A., ANDERSSON, M. B., GILLESPIE-BROWN, J., CLERK, A., GLENNON, P. E., FULLER, S. J., & SUGDEN, P. H. (1996). Adrenergic receptor stimulation of the mitogen-activated protein kinase cascade and cardiac hypertrophy. Biochemical Journal. https://doi.org/10.1042/bj3140115
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.